Full List of Publications
Selected Publications
Vlachavas EI, Voutetakis K, Kosmidou V, Tsikalakis S, Roditis S, Pateas K, Kim R, Pagel K, Wolf S, Warsow G, Dimitrakopoulou-Strauss A, Zografos GN, Pintzas A, Betge J, Papadodima O, and Wiemann S. Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancer. Mol Oncol, (2025). PMID: https://www.ncbi.nlm.nih.gov/pubmed/39876058
Sumer OE, Schelzig K, Jung J, Li X, Moros J, Schwarzmuller L, Sen E, Karolus S, Worner A, de Melo Costa VR, Nataraj NB, Vlachavas EI, Gerhauser C, Muller-Decker K, Helm D, Yarden Y, Michels BE, and Korner C. Selective arm-usage of pre-miR-1307 dysregulates angiogenesis and affects breast cancer aggressiveness. BMC Biol 23, 25 (2025). PMID: https://www.ncbi.nlm.nih.gov/pubmed/39849498
Radke J, Ishaque N, Koll R, Gu Z, Schumann E, Sieverling L, Uhrig S, Hubschmann D, Toprak UH, Lopez C, Hostench XP, Borgoni S, Juraeva D, Pritsch F, Paramasivam N, Balasubramanian GP, Schlesner M, Sahay S, Weniger M, Pehl D, Radbruch H, Osterloh A, Korfel A, Misch M, Onken J, Faust K, Vajkoczy P, Moskopp D, Wang Y, Jodicke A, Trumper L, Anagnostopoulos I, Lenze D, Kuppers R, Hummel M, Schmitt CA, Wiestler OD, Wolf S, Unterberg A, Eils R, Herold-Mende C, Brors B, Consortium IM-S, Siebert R, Wiemann S, and Heppner FL. The genomic and transcriptional landscape of primary central nervous system lymphoma. Nat Commun 13, 2558 (2022). PMID: https://www.ncbi.nlm.nih.gov/pubmed/35538064
Wahjudi LW, Bernhardt S, Abnaof K, Horak P, Kreutzfeldt S, Heining C, Borgoni S, Becki C, Berg D, Richter D, Hutter B, Uhrig S, Pfutze K, Leichsenring J, Glimm H, Brors B, von Kalle C, Stenzinger A, Korf U, Frohling S, and Wiemann S. Integrating proteomics into precision oncology. Int J Cancer 148, 1438-1451 (2021). PMID: https://www.ncbi.nlm.nih.gov/pubmed/32949162
Maia A, Gu Z, Koch A, Berdiel-Acer M, Will R, Schlesner M, and Wiemann S. IFNbeta1 secreted by breast cancer cells undergoing chemotherapy reprograms stromal fibroblasts to support tumour growth after treatment. Mol Oncol 15, 1308-1329 (2021). PMID: https://www.ncbi.nlm.nih.gov/pubmed/33476079
Ibing S, Michels BE, Mosdzien M, Meyer HR, Feuerbach L, and Korner C. On the impact of batch effect correction in TCGA isomiR expression data. NAR Cancer 3, zcab007 (2021). PMID: https://www.ncbi.nlm.nih.gov/pubmed/34316700
Berdiel-Acer M, Maia A, Hristova Z, Borgoni S, Vetter M, Burmester S, Becki C, Michels B, Abnaof K, Binenbaum I, Bethmann D, Chatziioannou A, Hasmann M, Thomssen C, Espinet E, and Wiemann S. Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts. Oncogene 40, 2651-2666 (2021). PMID: https://www.ncbi.nlm.nih.gov/pubmed/33692466
Haller F, Bieg M, Will R, Korner C, Weichenhan D, Bott A, Ishaque N, Lutsik P, Moskalev EA, Mueller SK, Bahr M, Woerner A, Kaiser B, Scherl C, Haderlein M, Kleinheinz K, Fietkau R, Iro H, Eils R, Hartmann A, Plass C, Wiemann S, and Agaimy A. Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands. Nature Communications 10, 368 (2019). PMID: https://www.ncbi.nlm.nih.gov/pubmed/30664630
Wiemann S, Pennacchio C, Hu Y, Hunter P, Harbers M, Amiet A, Bethel G, Busse M, Carninci P, Diekhans M, Dunham I, Hao T, Harper JW, Hayashizaki Y, Heil O, Hennig S, Hotz-Wagenblatt A, Jang W, Jöcker A, Kawai J, Koenig C, Korn B, Lambert C, LaBeau A, Lu S, Maurer J, Moore T, Ohara O, Park J, Rolfs A, Selehi-Ashtiani K, Seiler C, Simmons B, van Brabant Smith A, Steel J, Wagner L, Weaver T, Wellenreuther R, Yan S, Vidal M, Gerhard DS, LaBaer J, Temple G, and Hill DE. The ORFeome Collaboration: a genome-scale human ORF-clone resource. Nat Methods 13, 191-192 (2016). PMID: https://www.ncbi.nlm.nih.gov/pubmed/26914201
Keklikoglou I, Hosaka K, Bender C, Bott A, Koerner C, Mitra D, Will R, Woerner A, Muenstermann E, Wilhelm H, Cao Y, and Wiemann S. MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes. Oncogene 34, 4867-4878 (2015). PMID: https://www.ncbi.nlm.nih.gov/pubmed/25500542
Korner C, Keklikoglou I, Bender C, Worner A, Munstermann E, and Wiemann S. MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C epsilon (PKCepsilon). J Biol Chem 288, 8750-8761 (2013). PMID: https://www.ncbi.nlm.nih.gov/pubmed/23364795
Keklikoglou I, Koerner C, Schmidt C, Zhang JD, Heckmann D, Shavinskaya A, Allgayer H, Guckel B, Fehm T, Schneeweiss A, Sahin O, Wiemann S, and Tschulena U. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-kappaB and TGF-beta signaling pathways. Oncogene 31, 4150-4163 (2012). PMID: https://www.ncbi.nlm.nih.gov/pubmed/22158050
Taylor CF, Field D, Sansone SA, Aerts J, Apweiler R, Ashburner M, Ball CA, Binz PA, Bogue M, Booth T, Brazma A, Brinkman RR, Michael Clark A, Deutsch EW, Fiehn O, Fostel J, Ghazal P, Gibson F, Gray T, Grimes G, Hancock JM, Hardy NW, Hermjakob H, Julian RK, Jr., Kane M, Kettner C, Kinsinger C, Kolker E, Kuiper M, Le Novere N, Leebens-Mack J, Lewis SE, Lord P, Mallon AM, Marthandan N, Masuya H, McNally R, Mehrle A, Morrison N, Orchard S, Quackenbush J, Reecy JM, Robertson DG, Rocca-Serra P, Rodriguez H, Rosenfelder H, Santoyo-Lopez J, Scheuermann RH, Schober D, Smith B, Snape J, Stoeckert CJ, Jr., Tipton K, Sterk P, Untergasser A, Vandesompele J, and Wiemann S. Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project. Nat Biotechnol 26, 889-896 (2008). PMID: https://www.ncbi.nlm.nih.gov/pubmed/18688244
Wiemann S, Arlt D, Huber W, Wellenreuther R, Schleeger S, Mehrle A, Bechtel S, Sauermann M, Korf U, Pepperkok R, Sultmann H, and Poustka A. From ORFeome to biology: a functional genomics pipeline. Genome Res 14, 2136-2144 (2004). PMID: https://www.ncbi.nlm.nih.gov/pubmed/15489336
Wiemann S, Weil B, Wellenreuther R, Gassenhuber J, Glassl S, Ansorge W, Bocher M, Blocker H, Bauersachs S, Blum H, Lauber J, Dusterhoft A, Beyer A, Kohrer K, Strack N, Mewes HW, Ottenwalder B, Obermaier B, Tampe J, Heubner D, Wambutt R, Korn B, Klein M, and Poustka A. Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs. Genome Res 11, 422-435 (2001). PMID: https://www.ncbi.nlm.nih.gov/pubmed/11230166
Smahi A, Courtois G, Vabres P, Yamaoka S, Heuertz S, Munnich A, Israel A, Heiss NS, Klauck SM, Kioschis P, Wiemann S, Poustka A, Esposito T, Bardaro T, Gianfrancesco F, Ciccodicola A, D'Urso M, Woffendin H, Jakins T, Donnai D, Stewart H, Kenwrick SJ, Aradhya S, Yamagata T, Levy M, Lewis RA, and Nelson DL. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature 405, 466-472 (2000). PMID: https://www.ncbi.nlm.nih.gov/pubmed/10839543
Simpson JC, Wellenreuther R, Poustka A, Pepperkok R, and Wiemann S. Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing. EMBO Rep 1, 287-292 (2000). PMID: https://www.ncbi.nlm.nih.gov/pubmed/11256614
Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, Poustka A, and Dokal I. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nature Genet 19, 32-38 (1998). PMID: https://www.ncbi.nlm.nih.gov/pubmed/9590285
Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, von Deimling A, and Poustka A. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nature Genet 17, 32-39 (1997). PMID: https://www.ncbi.nlm.nih.gov/pubmed/9288095